158 related articles for article (PubMed ID: 12004326)
21. Bullous pemphigoid.
Korman N
J Am Acad Dermatol; 1987 May; 16(5 Pt 1):907-24. PubMed ID: 3294944
[TBL] [Abstract][Full Text] [Related]
22. A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin.
Domloge-Hultsch N; Benson P; Gammon WR; Yancey KB
Arch Dermatol; 1992 Aug; 128(8):1096-101. PubMed ID: 1379792
[TBL] [Abstract][Full Text] [Related]
23. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
24. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
25. Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone.
Yamane N; Sawamura D; Nishie W; Abe M; Kodama K; Adachi K; Nakamura H; Ishii N; Hashimoto T; Shimizu H
Br J Dermatol; 2007 May; 156(5):1075-8. PubMed ID: 17381449
[No Abstract] [Full Text] [Related]
26. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid.
Shimizu A; Funakoshi T; Ishibashi M; Yoshida T; Koga H; Hashimoto T; Amagai M; Ishiko A
Br J Dermatol; 2013 Mar; 168(3):647-55. PubMed ID: 22963596
[TBL] [Abstract][Full Text] [Related]
28. Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone.
Motegi S; Abe M; Tamura A; Ishii N; Hashimoto T; Ishikawa O
J Dermatol; 2005 Oct; 32(10):809-12. PubMed ID: 16361732
[TBL] [Abstract][Full Text] [Related]
29. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
Drerup KA; Wehkamp U
Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
[TBL] [Abstract][Full Text] [Related]
30. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
31. Bullous pemphigoid and related subepidermal autoimmune blistering diseases.
Olasz EB; Yancey KB
Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884
[TBL] [Abstract][Full Text] [Related]
32. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
34. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
35. Dapsone for the treatment of bullous pemphigoid.
Piamphongsant T
Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
[No Abstract] [Full Text] [Related]
36. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
J Am Acad Dermatol; 2021 Jul; 85(1):18-27. PubMed ID: 33684494
[TBL] [Abstract][Full Text] [Related]
37. The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2.
Hofmann SC; Voith U; Sasaki T; Trüeb RM; Nischt R; Bruckner-Tuderman L
J Invest Dermatol; 2008 Jan; 128(1):87-95. PubMed ID: 17637825
[TBL] [Abstract][Full Text] [Related]
38. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis.
Yamada T; Suzuki M; Koike Y; Kida K; Murata S; Ishii N; Hashimoto T; Ohtsuki M
Dermatology; 2006; 212(4):381-4. PubMed ID: 16707891
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
Kitayama S; Makino T; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
J Dermatol; 2023 Sep; 50(9):1194-1198. PubMed ID: 37082790
[TBL] [Abstract][Full Text] [Related]
40. Vesicular pemphigoid--ultrastructural and immunoelectron microscopic study.
Hayakawa K; Shimizu H; Amagai M; Harada T; Nishikawa T; Yamasaki Y
Dermatologica; 1989; 178(4):213-6. PubMed ID: 2670619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
